Literature DB >> 17439701

Hyperbaric oxygen in traumatic brain injury.

Sarah B Rockswold1, Gaylan L Rockswold, Archie Defillo.   

Abstract

OBJECTIVES: This critical literature review examines historical and current investigations on the efficacy and mechanisms of hyperbaric oxygen (HBO) treatment in traumatic brain injury (TBI). Potential safety risks and oxygen toxicity, as well as HBO's future potential, are also discussed.
METHODS: Directed literature review.
RESULTS: Historically, cerebral vasoconstriction and increased oxygen availability were seen as the primary mechanisms of HBO in TBI. HBO now appears to be improving cerebral aerobic metabolism at a cellular level, namely, by enhancing damaged mitochondrial recovery. HBO given at the ideal treatment paradigm, 1.5 ATA for 60 minutes, does not appear to produce oxygen toxicity and is relatively safe. DISCUSSION: The use of HBO in TBI remains controversial. Growing evidence, however, shows that HBO may be a potential treatment for patients with severe brain injury. Further investigations, including a multicenter prospective randomized clinical trial, will be required to definitively define the role of HBO in severe TBI.

Entities:  

Mesh:

Year:  2007        PMID: 17439701     DOI: 10.1179/016164107X181798

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  20 in total

1.  Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports.

Authors:  Kenneth P Stoller
Journal:  Med Gas Res       Date:  2011-07-05

Review 2.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

3.  Hyperbaric oxygen therapy ameliorates local brain metabolism, brain edema and inflammatory response in a blast-induced traumatic brain injury model in rabbits.

Authors:  Yongming Zhang; Yanyan Yang; Hong Tang; Wenjiang Sun; Xiaoxing Xiong; Daniel Smerin; Jiachuan Liu
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996

4.  Quantitative evaluation of hyperbaric oxygen efficacy in experimental traumatic brain injury: an MRI study.

Authors:  Xiao-Er Wei; Yue-Hua Li; Hui Zhao; Ming-Hua Li; Min Fu; Wen-Bin Li
Journal:  Neurol Sci       Date:  2013-08-18       Impact factor: 3.307

5.  Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders.

Authors:  Bryan Jepson; Doreen Granpeesheh; Jonathan Tarbox; Melissa L Olive; Carol Stott; Scott Braud; J Helen Yoo; Andrew Wakefield; Michael S Allen
Journal:  J Autism Dev Disord       Date:  2011-05

6.  Hyperbaric Oxygen Protects Against Cerebral Damage in Permanent Middle Cerebral Artery Occlusion Rats and Inhibits Autophagy Activity.

Authors:  KongMiao Lu; HaiRong Wang; XiaoLi Ge; QingHua Liu; Miao Chen; Yong Shen; Xuan Liu; ShuMing Pan
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

7.  Normobaric hyperoxia in traumatic brain injury: does brain metabolic state influence the response to hyperoxic challenge?

Authors:  Anna Vilalta; Juan Sahuquillo; Maria-Angels Merino; Maria-Antonia Poca; Angel Garnacho; Tamara Martínez-Valverde; Mithilesh Dronavalli
Journal:  J Neurotrauma       Date:  2011-06-30       Impact factor: 5.269

Review 8.  Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.

Authors:  Gang Cheng; Rong-hua Kong; Lei-ming Zhang; Jian-ning Zhang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

9.  A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population.

Authors:  Nathan K Evanson; Andrea L Paulson; Brad G Kurowski
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-02-17

Review 10.  Bench-to-bedside review: oxygen as a drug.

Authors:  Haim Bitterman
Journal:  Crit Care       Date:  2009-02-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.